1 - 8 of 8

Robert T. Schultz, PhD

Robert T. Schultz

Dr. Schultz's research involves using magnetic resonance imaging to understand brain mechanisms and to create biomarkers that predict who has autism spectrum disorder (ASD), who will develop the disorder, and who will respond well to different interventions. More recently, he has developed a technology and innovation lab to exploit advances in perceptual computing, in order to develop more robust measurements of quantitative traits.


Shaon Sengupta, MBBS, MPH

Shaon Sengupta

Dr. Sengupta is a neonatologist and physician scientist with a long-standing interest in lung health. She studies the mechanisms of circadian regulation of lung inflammation, injury, and repair; and the effect of early life exposures on development and function of pulmonary circadian networks in adulthood.


Rachana Shah, MD, MSTR

Rachana Shah

Dr. Shah's research is centered on understanding obesity and its related complications. Her current work includes clinical and translational studies exploring pathophysiology and modulation of obesity-related adipose tissue and systemic inflammation using human cell lines and clinical trials. She is also involved in clinical studies of outcomes and risk factors of polycystic ovarian syndrome and type 2 diabetes in teens.


Michael Silverman, MD, PhD

Michael Silverman

Dr. Silverman studies the fundamental aspects of early-life commensal microbes that influence immune system development and function. He discovered that the MHC-II E molecule prevents type 1 diabetes by shaping the intestinal microbiota early in life.


Virginia A. Stallings, MD

Virginia A. Stallings

Dr. Stallings is working on intervention trials involving three chronic diseases with nutrition-related abnormalities resulting in meaningful adverse outcomes: cystic fibrosis (new drugs), sickle cell disease (vitamin A) and chronic pancreatitis (enzyme replacement drug).


Andrew P. Steenhoff, MBBCh, DCH

Andrew P. Steenhoff

Dr. Steenhoff is medical director of the Global Health Center at Children's Hospital. He serves as a global health advocate for children, seeking to optimize mutually beneficial partnerships between clinical and academic institutions in diverse settings.


Kathleen E. Sullivan, MD, PhD

Photo of Kathleen E. Sullivan

Dr. Sullivan's research focuses on new and rare immunodeficiencies. She has a long-standing interest in one of the most common of the primary immunodeficiencies – chromosome 22q11.2 deletion syndrome. She also investigates common variable immunodeficiency, as well as the genetics and epigenetics of systemic lupus erythematosus.